Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer

NCT03818997 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Stopped Company decision

Conditions

Esophageal Cancer
Biliary Tract Cancer
GastroEsophageal Cancer
Hepatobiliary Neoplasm

Interventions

DRUG: DKN-01
DRUG: Atezolizumab
DRUG: Paclitaxel

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]
[object Object]